The Hidden Link Between HIV and Heart Disease

For years, HIV was considered primarily an immune deficiency disease. However, advances in treatment have dramatically increased the lifespan of individuals living with HIV, revealing a significant and growing concern: an increased risk of cardiovascular disease (CVD). This article explores the complex relationship between HIV and heart health, examining the underlying mechanisms, clinical manifestations, and current approaches to diagnosis and treatment.

The Rising Prevalence of Cardiovascular Disease in People Living with HIV

As HIV treatment allows individuals to live longer, healthier lives, the prevalence of cardiac complications has become increasingly apparent. Studies indicate that between 28% and 73% of people living with HIV experience some form of cardiac involvement ¹. This is a substantial increase compared to the general population, highlighting the unique challenges faced by this patient group.

Understanding the Pathogenesis of HIV-Associated Cardiovascular Disease

The link between HIV and CVD is multifaceted. Several factors contribute to this increased risk:

• Direct Viral Effects: HIV can directly infect heart cells, leading to inflammation and damage.
• Chronic Inflammation: HIV infection is characterized by chronic immune activation and inflammation, even with antiretroviral therapy. This persistent inflammation contributes to the development of atherosclerosis (plaque buildup in the arteries).
• Antiretroviral Therapy (ART): Although life-saving, some ART medications have been associated with metabolic abnormalities, such as high cholesterol and insulin resistance, which are known risk factors for CVD.
• Traditional Risk Factors: People living with HIV may have a higher prevalence of traditional CVD risk factors like hypertension, diabetes, and smoking.

Recent research has deepened our understanding of these mechanisms, particularly through advancements in cardiac imaging and immunology ².

Clinical Manifestations: What Types of Heart Disease are Seen in HIV?

HIV-associated CVD can manifest in various forms, including:

• Cardiomyopathy: A disease of the heart muscle that can lead to heart failure. This is a particularly significant concern in HIV-positive individuals ³.
• Coronary Artery Disease: Narrowing of the arteries that supply blood to the heart, leading to chest pain (angina) and increased risk of heart attack.
• Heart Failure: A condition where the heart cannot pump enough blood to meet the body’s needs.
• Arrhythmias: Irregular heartbeats.
• Pericardial Disease: Inflammation of the sac surrounding the heart.

Diagnosis and Management

Early diagnosis and management are crucial for improving outcomes in people living with HIV and CVD. Diagnostic approaches include:

• Electrocardiogram (ECG): To assess heart rhythm.
• Echocardiogram: An ultrasound of the heart to evaluate its structure and function.
• Cardiac Magnetic Resonance Imaging (MRI): Provides detailed images of the heart.
• Biomarkers: Blood tests to measure levels of cardiac enzymes and other indicators of heart damage.

Management strategies focus on:

• Antiretroviral Therapy: Suppressing HIV replication to reduce inflammation and viral load.
• Management of Traditional Risk Factors: Controlling blood pressure, cholesterol, and blood sugar.
• Lifestyle Modifications: Encouraging a healthy diet, regular exercise, and smoking cessation.
• Cardiac Medications: Using medications to treat specific heart conditions, such as heart failure or arrhythmias.

The Evolving Landscape of HIV and Cardiovascular Health

The understanding of cardiovascular involvement in HIV patients has evolved significantly with improved life expectancy and advancements in research ⁴. Continued research is essential to develop more effective strategies for preventing and treating HIV-associated CVD, ultimately improving the long-term health and well-being of individuals living with HIV.